Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions

NCT00872833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2015-10-07

Study results available
· View outcomes & findings →

Summary

Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Carelon Research

    lead OTHER

Principal Investigators

  • Dru Foote, NP · Children's Hospital and Research Institute Oakland

  • Jeanne Boudreaux, MD · Children's Healthcare of Atlanta

  • Thomas Coates, MD · Children's Hospital Los Angeles

  • Elliott Vichinsky, MD · UCSF Benioff Children's Hospital Oakland

  • Michael Jeng, MD · Stanford University

  • Janet Kwiatkowski, MD · Children's Hospital of Philadelphia

  • Nancy Olivieri, MD · University Health Network - Toronto General Hospital

  • Patricia J. Giardina, MD · Weill Medical College of Cornell

  • Brigitta Mueller, MD · Baylor College of Medicine

  • Alexis A. Thompson, MD, MPH · Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00872833 on ClinicalTrials.gov